Updated National Patient Safety Goal for Anticoagulants

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

3 posts / 0 new
Log in or register to post comments
Last post
Tue, 01/15/2019 - 16:42
#1
Courtney Sutton
Courtney Sutton's picture
Offline
Last seen: 5 years 10 months ago
Joined: 05/03/2017 - 22:28
Updated National Patient Safety Goal for Anticoagulants

Hello!

For those of you at hospitals that serve pediatric patients, how do you interpret the NPSG.15.01.01 EP 7 which states "For pediatric patients, prefilled syringe products should only be used if specifically designed for children"? We're curious how to address this EP with enoxaparin syringes, because (as the EP also states), there are safety concerns with using the vial.

Thanks,
Courtney Sutton, PharmD, BCPPS

Top